Thomas M. Abbott

1.0k total citations
17 papers, 739 citations indexed

About

Thomas M. Abbott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Thomas M. Abbott has authored 17 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Thomas M. Abbott's work include Ovarian cancer diagnosis and treatment (4 papers), Lung Cancer Research Studies (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Thomas M. Abbott is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Lung Cancer Research Studies (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Thomas M. Abbott collaborates with scholars based in United States and Somalia. Thomas M. Abbott's co-authors include Elizabeth H. Hammond, Donald J. Dudley, Raymond A. Daynes, Murray D. Mitchell, D. Ware Branch, James C. Overall, Martha L. Slattery, Thomas K. French, John Ward and Daniel O. Clegg and has published in prestigious journals such as Cancer, American Journal of Epidemiology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Thomas M. Abbott

15 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Abbott United States 12 306 148 131 114 111 17 739
Hugh Parry United Kingdom 15 190 0.6× 79 0.5× 96 0.7× 231 2.0× 40 0.4× 24 972
Vinay Sakhuja India 16 113 0.4× 138 0.9× 146 1.1× 51 0.4× 67 0.6× 58 839
U Nieminen Finland 16 69 0.2× 200 1.4× 65 0.5× 89 0.8× 117 1.1× 67 1.0k
E. B. Haagsma Netherlands 13 155 0.5× 232 1.6× 27 0.2× 42 0.4× 104 0.9× 28 668
Chung Ying Leung China 7 148 0.5× 168 1.1× 36 0.3× 151 1.3× 88 0.8× 11 1.1k
Eoghan McCarthy Ireland 17 305 1.0× 95 0.6× 34 0.3× 277 2.4× 70 0.6× 44 787
Hiroo Maeda Japan 17 76 0.2× 284 1.9× 135 1.0× 303 2.7× 71 0.6× 53 827
Pauline Mackintosh United Kingdom 16 145 0.5× 201 1.4× 87 0.7× 270 2.4× 30 0.3× 35 789
Sonali Narain United States 22 643 2.1× 286 1.9× 53 0.4× 557 4.9× 117 1.1× 40 1.3k
Sevinç Emre Türkiye 15 115 0.4× 79 0.5× 58 0.4× 85 0.7× 14 0.1× 43 990

Countries citing papers authored by Thomas M. Abbott

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Abbott more than expected).

Fields of papers citing papers by Thomas M. Abbott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Abbott. The network helps show where Thomas M. Abbott may publish in the future.

Co-authorship network of co-authors of Thomas M. Abbott

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Abbott. A scholar is included among the top collaborators of Thomas M. Abbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Abbott. Thomas M. Abbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lee, Christopher M., Cherie J. Hayostek, Thomas M. Abbott, Peter Hathaway, & Gordon A. Watson. (2005). Nasopharyngeal Carcinoma with Axillary Node Involvement as a Component of Failure following Chemoradiotherapy. Ear Nose & Throat Journal. 84(3). 159–162.
2.
Stephenson, Robert A., Richard G. Middleton, & Thomas M. Abbott. (1997). Wide Excision (Nonnerve Sparing) Radical Retropubic Prostatectomy Using an Initial Perirectal Dissection. The Journal of Urology. 157(1). 251–255. 34 indexed citations
3.
Stephenson, Robert A., Richard G. Middleton, & Thomas M. Abbott. (1997). Wide Excision (Nonnerve Sparing) Radical Retropubic Prostatectomy Using an Initial Perirectal Dissection. The Journal of Urology. 251–255. 2 indexed citations
4.
Brown, K A, et al.. (1996). bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.. PubMed. 9(4). 430–8. 39 indexed citations
5.
Ward, John H., et al.. (1991). Isolated calcaneal metastasis in a patient with endometrial adenocarcinoma. Cancer. 67(7). 1979–1983. 34 indexed citations
6.
Gardner, John W., et al.. (1991). Is Vaginal Douching Related to Cervical Carcinoma?. American Journal of Epidemiology. 133(4). 368–375. 40 indexed citations
7.
Branch, D. Ware, Donald J. Dudley, Murray D. Mitchell, et al.. (1990). Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. American Journal of Obstetrics and Gynecology. 163(1). 210–216. 255 indexed citations
8.
Murray, Kevin D., et al.. (1990). Correlation of Gross and Microscopic Appearance of Skin Buttons in Total Artificial Heart Animals. ASAIO Transactions. 36(4). 825–829. 1 indexed citations
9.
Slattery, Martha L., Thomas M. Abbott, James C. Overall, et al.. (1990). Dietary Vitamins A, C, and E and Selenium as Risk Factors for Cervical Cancer. Epidemiology. 1(1). 8–15. 60 indexed citations
10.
Alberts, David S., Robert V. O’Toole, Thomas M. Abbott, et al.. (1989). Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: A Southwest Oncology Group study. Gynecologic Oncology. 32(1). 16–21. 8 indexed citations
11.
Slattery, Martha L., et al.. (1989). SEXUAL ACTIVITY, CONTRACEPTION, GENITAL INFECTIONS, AND CERVICAL CANCER: SUPPORT FOR A SEXUALLY TRANSMITTED DISEASE HYPOTHESIS. American Journal of Epidemiology. 130(2). 248–258. 90 indexed citations
12.
Alberts, David S., Robert V. O’Toole, Thomas M. Abbott, et al.. (1989). Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: A Southwest Oncology Group study. Gynecologic Oncology. 32(1). 8–15. 15 indexed citations
14.
Jolles, Christopher J., James H. Beeson, & Thomas M. Abbott. (1985). Progesterone production in adenocarcinoma of the colon metastatic to the ovaries.. PubMed. 65(6). 853–7. 2 indexed citations
15.
Abbott, Thomas M., William J. Hermann, & Robert E. Scully. (1984). Ovarian Fetiform Teratoma (Homunculus) in a 9-Year-Old Girl. International Journal of Gynecological Pathology. 2(4). 392–402. 28 indexed citations
16.
Kelly, Michael T., Thomas M. Abbott, DeVon C. Hale, et al.. (1983). Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia.. PubMed. 250(16). 2185–8. 23 indexed citations
17.
Cannon, Grant W., John Ward, Daniel O. Clegg, Cecil O. Samuelson, & Thomas M. Abbott. (1983). Acute lung disease associated with low‐dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis & Rheumatism. 26(10). 1269–1274. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026